Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 181 AL 195

Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents

Pourshojaei Y, Eskandari K, Asadipour A.

Mini Rev Med Chem. 2019;19(19):1577-1598. doi: 10.2174/1389557519666190719143112.

Critical evaluation of current Alzheimer's drug discovery (2018-19) & futuristic Alzheimer drug model approach

Dorababu A.

Bioorg Chem. 2019 Dec;93:103299. doi: 10.1016/j.bioorg.2019.103299. Epub 2019 Sep 19.

Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning

Kabir MT, Uddin MS, Begum MM, Thangapandiyan S, Rahman MS, Aleya L, Mathew B, Ahmed M, Barreto GE, Ashraf GM.

Curr Pharm Des. 2019;25(33):3519-3535. doi: 10.2174/1381612825666191008103141.

Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease

Morsy A, Trippier PC.

J Alzheimers Dis. 2019;72(s1):S145-S176. doi: 10.3233/JAD-190744.

NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy

Kabir MT, Sufian MA, Uddin MS, Begum MM, Akhter S, Islam A, Mathew B, Islam MS, Amran MS, Md Ashraf G.

Curr Pharm Des. 2019;25(33):3506-3518. doi: 10.2174/1381612825666191011102444.

Resveratrol in experimental Alzheimer's disease models: A systematic review of preclinical studies

Chen JY, Zhu Q, Zhang S, OuYang D, Lu JH.

Pharmacol Res. 2019 Dec;150:104476. doi: 10.1016/j.phrs.2019.104476. Epub 2019 Oct 9.

The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review

Ahmad SS, Khan S, Kamal MA, Wasi U.

CNS Neurol Disord Drug Targets. 2019;18(9):657-667. doi: 10.2174/1871527318666191011145941.

Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease

Naushad M, Durairajan SSK, Bera AK, Senapati S, Li M.

Planta Med. 2019 Nov;85(17):1316-1325. doi: 10.1055/a-1019-9819. Epub 2019 Oct 16.

Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease

Dubey T, Chinnathambi S.

Arch Biochem Biophys. 2019 Nov 15;676:108153. doi: 10.1016/j.abb.2019.108153. Epub 2019 Oct 14.

Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease

Chan HH, Koh RY, Lim CL, Leong CO.

Curr Alzheimer Res. 2019;16(10):907-918. doi: 10.2174/1567205016666191023102422.

Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches

Tibbo AJ, Tejeda GS, Baillie GS.

Biochem Soc Trans. 2019 Oct 31;47(5):1557-1565. doi: 10.1042/BST20190763.

Tubulin: Structure, Functions and Roles in Disease

Binarová P, Tuszynski J.

Cells. 2019 Oct 22;8(10):1294. doi: 10.3390/cells8101294.

Investigational BACE inhibitors for the treatment of Alzheimer's disease

Imbimbo BP, Watling M.

Expert Opin Investig Drugs. 2019 Nov;28(11):967-975. doi: 10.1080/13543784.2019.1683160. Epub 2019 Oct 29.

Editorial: Can Digital Technology Advance the Development of Treatments for Alzheimer's Disease?

Mc Carthy M, Schueler P.

J Prev Alzheimers Dis. 2019;6(4):217-220. doi: 10.14283/jpad.2019.32.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias